Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

Clinical trial NCT02698579 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02698579
Sponsor: Genetix Biotherapeutics Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Cerebral Adrenoleukodystrophy (CALD)Adrenoleukodystrophy (ALD)X-Linked Adrenoleukodystrophy (X-ALD)

Start date: 2016-01-22
Primary completion: 2038-08-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.